Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KO vs GSK✓SelectedUSD · GSKKO vs GSK performance historyLatest closeAs of-2.04%11/19
Stock and ETF performance explorer

KO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4,659.0%
GSK return
+1,646.5%
Excess return
+3,012.5%
Maximum drawdown
-55.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.5%-1.6%
7D-1.4%-4.7%+3.3%0.0%
30D+2.8%-4.7%+7.5%+4.1%
3M+7.0%-8.8%+15.7%+9.6%
6M+18.8%-4.6%+23.4%+20.0%
YTD+40.1%+1.0%+39.1%+38.8%
1Y+38.7%+6.9%+31.8%+35.2%
3Y+82.9%+52.5%+30.4%+58.4%
5Y+101.8%+40.3%+61.5%+76.9%
10Y+220.2%+99.0%+121.3%+151.9%
All+4,659.0%+1,646.5%+3,012.5%+1,517.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling